Table 1.
Results from the three GEE analyses testing the associations between baseline measures of Atrophy, WMH, and their combined effects on rate of cognitive decline. Each analysis was run with (Model 1) and without (Model 2) vascular risk factor variables. The main effect of “Time” shows the rate of mMMS change per 1 year interval. Interactions involving Time show the annualized rate of change on mMMS as a function of each unit of the independent variable. For example, the “Time X Bicaudate Ratio” interaction shows the impact of baseline atrophy measures on rate of annualized mMMS change (i.e., for every 1% increase in baseline bicaudate ratio, there is an associated 0.316 point decrease in mMMS score per year).
GEE Analysis | Variable of Interest | Model 1* | Model 2¥ | ||
---|---|---|---|---|---|
β | P | β | P | ||
Atrophy | Time | 1.619 | 0.485 | 2.964 | 0.116 |
Bicaudate Ratio | −0.786 | 0.023 | −0.497 | 0.092 | |
Time X Bicaudate ratio | −0.316 | 0.036 | −0.415 | <0.001 | |
WMH | Time | −2.706 | <0.001 | −3.160 | <0.001 |
Scheltens Score | −0.082 | 0.683 | −0.106 | 0.558 | |
Time X Scheltens Score | −0.173 | 0.028 | −0.122 | 0.71 | |
Atrophy + WMH | Time | −1.988 | 0.295 | 0.977 | 0.504 |
Bicaudate Ratio | −0.445 | 0.148 | −0.427 | 0.121 | |
Scheltens Score | −0.224 | 0.245 | −0.145 | 0.360 | |
Time X Bicaudate Ratio | −6.277 | 0.620 | −0.278 | 0.003 | |
Time X Scheltens Score | 0.968 | 0.049 | 0.512 | 0.094 | |
Time X Bicaudate Ratio X Scheltens Score | −6.061 | 0.018 | −3.250 | 0.050 |
Model adjusted for Age, Sex, Education, APOE4, Diabetes, Dyslipidemia, CAD, and Hypertension
Model adjusted for Age, Sex, and Education